OTCBB : $ALRT
FDA APPROVAL NEWS ON SEPTEMBER 19, 2017
ALR Technologies, Inc. (OTCBB: ALRT) is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases.
ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website.
Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals.
Currently, the company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
ALRT received FDA clearance for the HeC system in October, 2011. Company CEO, Sidney Chan, commented, "We are pleased to reach this milestone and are
eager to introduce to market this cross-platform technology. The HeC System represents a breakthrough for clinician/patient communication to enhance disease
management and improve health outcomes. The System provides the potential to achieve significant savings to the US healthcare system through enhanced adherence to
care plans. In anticipation of the FDA clearance, we have been cultivating relationships with manufacturers of diabetes test supplies and insurance
companies to help facilitate a successful launch."
President and COO Lawrence Weinstein added, "Diabetes management represents the initial chronic illness application for HeC and we plan to
expand upon that platform in 2012. A first-to-market product, the HeC System bridges gaps in current remote monitoring systems in a manner that is
efficient, effective and affordable. We anticipate a strong demand based upon our present relationships with industry leaders. Given the flexibility of the HeC System,
the potential is enormous. This FDA clearance is a major stride in our commitment to building long-term shareholder value as there is a wide spectrum of chronic
diseases which the HeC platform can be deployed to improve outcomes and contain costs."
HOW HEALTH e-CONNECT WORKS
Sidney S. Chan, CEO and Chairman
Mr. Chan has been involved in managing ALR Technologies since August 1997. Since then, he has played a pivotal role in the evolution of ALR Technologies into a public company. Mr. Chan has been extensively involved in the company's finances and product development.
Mr. Chan is an engineer who obtained his Bachelor of Engineering (Mining) degree with the distinction in Mineral Economics from McGill University in 1973. Larry Weinstein, President and Chief Operating Officer
Mr. Weinstein joined ALRT in July 2010, bringing over 25 years of medical device development and management experience from organizations such as Cordis Corporation, DHD Healthcare and PARI Respiratory Equipment.
Mr. Weinstein received a Bachelor of Science in Chemical Engineering degree from Rensselaer Polytechnic Institute. He earned both a Master of Science degree in Industrial Engineering and an MBA from the University of Miami. William S. Smith, Director, Commercial Strategy and External Affairs
William S. Smith has worked at senior levels in the private sector and in government. He has more than a decade of experience in healthcare. He served as Managing Director at NSI, a Washington-based government affairs firm. His clients have included major pharmaceutical and biotechnology companies where Mr. Smith has provided strategic advice on government affairs challenges.
Mr. Smith spent ten years at Pfizer, Inc, where he was Vice President for U.S. Public Affairs and Policy. In that role, Smith was the lead advisor on U.S. policy issues to Pfizer's major commercial businesses in the United States. Smith also ran Pfizer's state government affairs group, one of the largest such groups in corporate America.
Mr. Smith previously worked in government where he was on the staff of two Governors in Massachusetts, was a leadership aide to the Republican Leadership in the U.S. House of Representatives, and was a senior aide in the White House Office of National Drug Control Policy under President George H.W. Bush.
Mr. Smith is a graduate of Georgetown University and has a Masters in Politics from the Catholic University of America. Jerome P. Hickey, Director of Sales and Marketing
Mr. Hickey was most recently National Account Manager at Medicis Pharmaceutical Company, working with many of the largest healthcare payers in the U.S. Prior to Medicis, Mr. Hickey had extensive experience in sales at Pfizer, Inc., rising from a sales representative to assume such positions as Director of Managed Markets Training and Regional Director of Managed Markets for the New York region, one of Pfizer's most important sales regions. Mr. Hickey was responsible for delivering over 1.4 billion dollars in gross revenue at Pfizer. Kent Stoneking, Pharm. D., CDE, Director, Diabetes Care Facilitation
Dr. Stoneking is a Certified Diabetes Educator (CDE) who has gained extensive, hands-on experience working with a network of internal medicine and family practice physicians to assist patients with diabetes education and self-management training. He received his Doctor of Pharmacy from the University of Tennessee and is an affiliate member of the American Diabetes Association and the American Pharmacists Association. Dr. Stoneking is Chair of Pharmacy Practice at Union University School of Pharmacy, Jackson, Tennessee. Dr. Alfonso Salas, Director
Dr. Salas graduated with distinction from Universidad Metroplitana of Barranquilla, Colombia in 1983 with a Doctor of Medicine degree. He began practicing in Santa Marta, Columbia in rural medical facilities and the opened a private practice in 1984. He then worked as a physician with a number of shipping companies and became Medical Director in the office of the Ministry of Social Security and Labor of Columbia in 1991 doing medical assessments for work related accidents. In 1993 Dr. Salas was appointed Director of a Medical Service Plan of Columbia and with a support staff of more than thirty people, maintained a caseload, provided assessment procedures and referral services to hospitals, clinics, and specialists and organized and monitored clinical trials and clinical research in the pharmaceutical and medical field. Since 1995 Dr. Salas has operated his own business in Vancouver, British Columbia, providing medical based consulting services for corporations with a focus on budgeting, research and medical services. Kenneth Robulak, Director
From December 14, 1999 to January 31, 2001, Mr. Robulak was a member of the ALRT board of directors and from April 4, 2000 to January 31, 2001 Mr. Robulak was ALRT's chief financial officer, secretary, treasurer and vice president. Mr. Robulak resigned as an officer and director on January 31, 2001. At the time of his resignation, Mr. Robulak did not have any disagreements with ALRT relating to our operations, policies, or practices. Since August 2005, Mr. Robulak has served as a Director of Belle Harbor Owners Association, a not for profit company in Clearwater Beach, Florida. Since July 2007, Mr. Robulak has worked as a marketing consultant to Teco Metal Products, LLC, a technology based manufacturing Company with operations in Dallas, Texas and Guadalajara, Mexico . Mr. Robulak earned a Bachelor of Commerce degree in finance and marketing and is a Fellow of the Institute of Canadian Bankers.